HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 617 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,726,203 | -31.8% | 14,920 | -39.4% | 0.00% | -40.0% |
Q2 2023 | $2,532,045 | -52.4% | 24,621 | -49.4% | 0.01% | -50.0% |
Q1 2023 | $5,315,466 | -28.8% | 48,701 | -25.7% | 0.01% | -33.3% |
Q4 2022 | $7,460,869 | +175.0% | 65,562 | +49.6% | 0.02% | +150.0% |
Q3 2022 | $2,713,000 | -19.2% | 43,837 | +4.1% | 0.01% | -14.3% |
Q2 2022 | $3,359,000 | +9.5% | 42,100 | +35.9% | 0.01% | +16.7% |
Q1 2022 | $3,067,000 | -37.4% | 30,977 | -31.9% | 0.01% | -33.3% |
Q4 2021 | $4,901,000 | +30.3% | 45,476 | +32.5% | 0.01% | +12.5% |
Q3 2021 | $3,760,000 | +19.9% | 34,320 | +2.7% | 0.01% | +14.3% |
Q2 2021 | $3,136,000 | +8.2% | 33,415 | +6.0% | 0.01% | 0.0% |
Q1 2021 | $2,897,000 | +54.2% | 31,515 | +22.8% | 0.01% | +40.0% |
Q4 2020 | $1,879,000 | -48.9% | 25,669 | -45.8% | 0.01% | -54.5% |
Q3 2020 | $3,677,000 | +98.6% | 47,366 | +42.0% | 0.01% | +83.3% |
Q2 2020 | $1,851,000 | +171.0% | 33,347 | +6.4% | 0.01% | +100.0% |
Q1 2020 | $683,000 | – | 31,355 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |